Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

bayer co. (malaysia) sdn. bhd. - rivaroxaban micronized -

United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals ny llc - ticagrelor (unii: glh0314rvc) (ticagrelor - unii:glh0314rvc) - ticagrelor tablets are indicated to reduce the risk of cardiovascular death, myocardial infarction (mi), and stroke in patients with acute coronary syndrome (acs) or a history of mi. for at least the first 12 months following acs, it is superior to clopidogrel. ticagrelor tablets also reduce the risk of stent thrombosis in patients who have been stented for treatment of acs [see clinical studies (14.1)] . ticagrelor tablets are indicated to reduce the risk of a first mi or stroke in patients with coronary artery disease (cad) at high risk for such events [see clinical studies (14.2)]. while use is not limited to this setting, the efficacy of ticagrelor tablets were established in a population with type 2 diabetes mellitus (t2dm). ticagrelor tablets are contraindicated in patients with a history of intracranial hemorrhage (ich) because of a high risk of recurrent ich in this population [see clinical studies (14.1), (14.2)] . ticagrelor tablets are contraindicated in patients with active pathological bleeding

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - aprotinin - solution for injection - aprotinin 500,000/50 kiu/ml - antihemorrhagics

Malta - English - Medicines Authority

miller and miller chemicals unit 3, burnside industrial est, 49-53 roebuck road hainault, essex ig63ug, united kingdom - aprotinin - solution for injection - aprotinin 10,000 kiu/ml - antihemorrhagics

Malta - English - Medicines Authority

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - aprotinin - solution for injection - aprotinin 100000 kiu/ml - antihemorrhagics

Australia - English - Department of Health (Therapeutic Goods Administration)

swisse wellness pty ltd - iron (ii) glycinate, quantity: 88.8 mg (equivalent: iron, qty 24 mg); calcium ascorbate dihydrate, quantity: 18.16 mg (equivalent: ascorbic acid, qty 15 mg); fructooligosaccharides, quantity: 80 mg; cyanocobalamin, quantity: 0.05 mg - tablet, film coated - excipient ingredients: citric acid; maltodextrin; silicon dioxide; hypromellose; microcrystalline cellulose; crospovidone; croscarmellose sodium; povidone; colloidal anhydrous silica; magnesium stearate; carnauba wax; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3000 - maintain/support energy production ; relieve weariness/tiredness/fatigue/feeling of weakness ; maintain/support general health and wellbeing ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; maintain/support healthy pregnancy ; maintain/support maternal health

Philippines - English - FDA (Food And Drug Administration)

the generics pharmacy inc - loratadine - tablet, film-coated - 10mg

Philippines - English - FDA (Food And Drug Administration)

abbott labs phils - loratadine - tablet, film-coated - 10mg

Philippines - English - FDA (Food And Drug Administration)

sandoz phils corp - loratadine - tablet, film coated - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

nordic pharma ltd - aprotinin - solution for infusion - 10000kallikrein inactivator unit/1ml